New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - botulinum toxin type a 50 u - powder for injection - 50 u - active: botulinum toxin type a 50 u excipient: albumin sodium chloride - · for the prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month with headache lasting 4 hours a day or longer, of which at least 8 days are with migraine)

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - botulinum toxin type a 200 u - powder for injection - 200 u - active: botulinum toxin type a 200 u excipient: albumin sodium chloride - · the treatment of urinary incontinence due to neurogenic detrusor overactivity (eg. spinal cord injury or multiple sclerosis) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

European Union - English - EMA (European Medicines Agency)

evolus pharma b.v. - botulinum toxin type a - skin aging - other muscle relaxants, peripherally acting agents - temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines), when the severity of the above facial lines has an important psychological impact in adults below 65 years of age.

Israel - English - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 300 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Israel - English - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 500 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - botulinum toxin type a - injection, powder, for solution - 200 units - botulinum toxin type a 200 units

Ireland - English - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals ireland - botulinum toxin type a - powder for solution for injection - 4 allergan units - other muscle relaxants, peripherally acting agents; botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder and solvent for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin